The Scientist - Home

BRUSSELS—European research ministers are making a last-ditch effort to break a stalemate over the Community's five-year budget for research and development. Last month the ministers rejected a Belgian plan for a budget of $6.4 billion (5.8 billion ECU)151;a compromise between the $8.5 billion demanded by the European Commission and the $4.4 billion suggested by the three largest member states (Britain, France and West Germany). At stake is the future of the EEC's collaborative research pro

GAITHERSBURG, MD—The government could attract and retain a greater share of top-quality scientists and engineers if it could offer them more competitive salaries, hire them more quickly, and award raises and promotions on individual performance. That belief, held by research administrators both inside and outside government, is the driving force behind a five-year experiment at the National Bureau of Standards. Responding to a successful demonstration project begun in 1980 at two Navy work

WASHINGTON—A National Science Foundation proposal to spend $50 million next year on up to 20 science and technology centers, touted by Director Erich Bloch as a partial solution to the country's economic problems, is actually an untested idea that has raised numerous questions among the scientific community. NSF is supporting three separate efforts, one in-house, to help it decide how to create, operate and evaluate such basic research facilities. Congress has already heard Xestimony from

BOSTON—A court settlement last month that requires an environmental assessment of the military's biological warfare program could bolster efforts to define the impact of other federally funded research programs. The Defense Department agreed to such an assessment February 12 to resolve a suit brought by the Foundation on Economic Trends, a public interest organization founded by Jeremy Rifkin. The suit, filed last fall in U.S. District Court, claimed that the Pentagon had violated the Nati

David T Kingsbury, assistant director for biological, behavioral and social sciences at the National Science Foundation, has been described as the Reagan administration's point man on biotechnology. As chairman of the Biotechnology Science Coordinating Committee formed under the White House Office of Science and Technology Policy, Kingsbury was the principal architect of the Coordinated Framework for Biotechnology, which President Reagan signed last June. After receiving his Ph.D. in 1971, Kings

The uncle I knew best was a noted mathematician, who reached the top of the French academia when he was 38 and I was 13. His example showed that science was not fully recorded in dusty tomes but was a flourishing enterprise, and becoming myself a scientist was always a familiar option. This might have set me now on the usual pattern of fond reminiscences of teachers and postdoctorate mentors. But, in fact, I seem to have fled from teachers, mentors and existing disciplines. As a result, no one i

TOKYO—An American physicist and two agronomists, one American and one Indian, will receive the 1987 Japan Prize at ceremonies here April 14. Theodore Maiman, the father of laser technology, is being honored for his work in electro-optics. In the category of improvements of biological functions, the award is being shared by Henry Beachell and Gurdev Khush. Maiman will receive a cash award of $330,000; Beachell and Khush will share an equal amount. The Prize, established in 1985, is awarded

WASHINGTON—The Howard Hughes Medical Institute has promised to increase its spending by $500 million during the next decade as part of an agreement this month that ends its longstanding dispute with the Internal Revenue Service. Researchers, science students, and teachers at U.S. schools and universities may eventually be among the beneficiaries of the settlement, which requires HHMI to spend an additional $50 million a year above the $200 million it now devotes to medical research. The ag

WASHINGTON—Biotechnology stocks, whose prices rose an average of 60 percent last year, should continue to do well this year as the industry expands, analysts predict, although individual companies may continue to have problems. Linda I. Miller, vice president for biotechnology research at Paine Webber Inc. in New York, last month told a seminar at The Brookings Institution here that the biotechnology industry has seen its risk factors decline and opportunities increase following the "turmo

CHICAGO—Universities should regulate, and possibly even ban, some relationships between students and those faculty with financial ties to industry, says a Harvard physician who has studied ties between academia and industry. His 1985 survey of almost 700 grad students and postdocs in biotechnology-related fields found that a majority believe the benefits of increased financial support of students and faculty by industry outweigh the risks. A little more than one-third were getting such sup

STOCKHOLM—The two largest biotechnology companies in Sweden have set up foreign research centers to compensate for a shortage of trained scientists at home. Pharmacia is developing a center for genetic engineering research in La Jolla, Calif., while Astra has recently opened a research facility in Bangalore, India. Both centers will be staffed by local scientists. "We cannot find the right people here in Sweden," said Sune Rosell, head of research and development for Astra. The company pla

WASHINGTON—The National Institutes of Health has halted further cuts in the size of new research grants, an action it took in response to a proposed cut in funding for this year, and begun to restore funds to grants that were reduced. On February 25 NIH reversed a decision, made January 21, that took between 4 and nearly 20 percent from each grant to make sure the agency did not run out of money before the end of the fiscal year September 30. The Reagan administration has proposed that $33